Nanoparticle-Based DNA Vaccine Protects Against SARS-CoV-2 Variants in Female Preclinical Models

Investigators developed lipid nanoparticles to provide safe and effective delivery of plasmid DNA and showed protection against variants of concerns in female small animal models.